[PubMed] [Google Scholar] [111].Hompesch M, Jones-Leone A, Carr MC, Matthews J, Zhi H, Young M, Morrow L, Reinhardt RR, Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus, Diabetes, obesity & metabolism, 17 (2015) 8290
The Dopamine Connection GLP1 receptors are involved in brain pathways connected to reward, appetite, motivation, and impulse regulation
These medications were originally developed to treat type 2 diabetes because of their ability to improve blood sugar control
Clinical trials are evaluating these new products alone and in combinations not currently available